Novo Nordisk | NVO - 流動負債





流動負債 変化する 日付
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Bausch Health Companies USD 4.54B 14M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Canopy Growth CAD 158.44M 60.15M 2026-03
Corcept Therapeutics USD 153.8M 4.62M 2026-06
Drreddys Laboratories INR 167.57B 165.8B 2026-03
Eli Lilly USD 47.74B 11.11B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Merck USD 27.73B 786M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 31.75B 374M 2026-06
Novo Nordisk DKK 239.08B 13.92B 2026-06
Novo Nordisk DKK 36.54B 188.62B 2026-06
Pacira USD 122.01M 13.22M 2026-06
Perrigo USD 1.05B 57.2M 2026-06
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 153.81M 32.88M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Supernus Pharmaceuticals USD 347.38M 26.55M 2026-06
Zoetis USD 2.06B 8M 2026-06